A Retrospective Study Characterizing Age at Key Clinical Disease Indicators Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States

Author(s)

Salvucci A1, Qian C2, Powell L2, Lynch D3, Vasco G4, Johnston K2, Tomazos I1
1PTC Therapeutics, South Plainfield, NJ, USA, 2Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada, 3CHOP, Philadelphia, PA, USA, 4Bambino Gesù Children's Hospital, Rome, Italy

OBJECTIVES: Friedreich Ataxia (FA) is a progressive and systemic neurologic movement disorder, characterized by worsening ataxia, scoliosis, loss of ambulation, and several secondary impacts. This study aimed to characterize the age at scoliosis, cardiomyopathy, and diabetes among a cohort of patients with FA, using retrospective United States (US) claims data.

METHODS: The US Merative MarketScan Commercial database from Aug 2010 to Sept 2020 was used. All incident patients with FA (ICD-9 334.0) prior to Oct 2015 were identified. Incidence was defined with an 18-month washout period. Included patients were followed up for 12-months. This 30-month period was used to observe the onset of various disease indicators by age at FA diagnosis.

RESULTS: Of the 269 patients with FA, 43(16.0%) were diagnosed <16 years (mean[range] age at diagnosis of 10.9[1-15]), 34(12.9%) between 16-24 years (20.2[16-24]), and 192(71.4%) were >24 years (46.1[25-64]). Within the 30-month period leading up to and following the initial FA diagnosis, the majority of the earlier onset patients had scoliosis (72.1% among those <16; 67.6% among 16-24; 13.5% among >24 years), with the mean(range) age being 10.6(1.0-14.7), 18.3(12.6-24.0), and 41.2(23.0-61.0) years at first captured incidence, respectively. Cardiomyopathy was most frequently observed among those diagnosed between the ages of 16-24 years (50.0%), followed by those <16 (37.2%) and >24 years (27.1%); with age estimates of 18.8(12.4-23.5), 10.8(7.1-14.4), and 39.3(23.8-62.5) years, respectively. Diabetes was not frequently observed among the earlier onset patients (7.0% among those <16; 8.8% among 16-24; 28.1% among >24 years), with age estimates of 8.8(2.6-12.7), 20.5(20.2-21.2), 47.4(21.5-62.2) years, respectively.

CONCLUSIONS: In this cross-sectional analysis, cardiomyopathy and scoliosis were observed in patients with FA starting in childhood and adolescence. Diabetes was observed more frequently in the older age at onset group. There is an unmet need for treatments that can be initiated at a young age and effectively delay disease progression.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

CO142

Topic

Clinical Outcomes, Study Approaches

Topic Subcategory

Clinical Outcomes Assessment

Disease

Neurological Disorders, Rare & Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×